EDGAR Filing Documents for 0001104659-24-031098

Form 8-K - Current report:

SEC Accession No. 0001104659-24-031098

Filing Date

2024-03-05

Accepted

2024-03-05 17:26:27

Documents

Period of Report

2024-03-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm248020d1_8k.htm iXBRL	8-K	37706
2	EXHIBIT 4.1	tm248020d1_ex4-1.htm	EX-4.1	95990
3	EXHIBIT 4.2	tm248020d1_ex4-2.htm	EX-4.2	91965
4	EXHIBIT 5.1	tm248020d1_ex5-1.htm	EX-5.1	9528
5	EXHIBIT 10.1	tm248020d1_ex10-1.htm	EX-10.1	94036
6	EXHIBIT 10.2	tm248020d1_ex10-2.htm	EX-10.2	191989
7	EXHIBIT 99.1	tm248020d1_ex99-1.htm	EX-99.1	12131
11	GRAPHIC	image_003.jpg	GRAPHIC	3368
	Complete submission text file	0001104659-24-031098.txt		851273

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	fwbi-20240303.xsd	EX-101.SCH	3027
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	fwbi-20240303_lab.xml	EX-101.LAB	34240
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	fwbi-20240303_pre.xml	EX-101.PRE	22367
22	EXTRACTED XBRL INSTANCE DOCUMENT	tm248020d1_8k_htm.xml	XML	3617

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431

Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020

First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)